Kessler Investment Group’s Endocyte, Inc. Common Stock ECYT Stock Holding History

Kessler Investment Group’s Portfolio ECYT Stock Details ECYT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-12,358	Closed	-$219K	–	147
2018 Q3	$219K	Buy	+12,358	New	+$212K	0.22%	57
2014 Q2	–	Sell	-8,331	Closed	-$198K	–	108
2014 Q1	$198K	Buy	8,331 +922	+12%	+$13.4K	0.42%	43
2013 Q4	$79K	Buy	7,409 +540	+8%	+$5.96K	0.15%	68
2013 Q3	$92K	Buy	6,869 +2,139	+45%	+$33.8K	0.25%	57
2013 Q2	$62K	Buy	+4,730	New	+$63.8K	0.18%	55

Other funds holding ECYT

OTC

Opera Trading Capital Paris, France $419M AUM 0.58% 1-Year Est. Return

Claro Advisors Boston, Massachusetts $830M AUM 21.8% 1-Year Est. Return

Kessler Investment Group's ECYT Position: Q4 2018 in Review

Kessler Investment Group sold out of Endocyte, Inc. Common Stock (ECYT) in Q4 2018, closing a stake of 12,358 shares — an estimated $219K sold.

Kessler Investment Group first reported a position in ECYT in Q2 2013 and held it in 5 quarters. The position peaked at $219K in Q3 2018. 2 funds tracked by Wall St. Rank hold ECYT as of Q4 2018.

Kessler Investment Group reported no remaining Endocyte, Inc. Common Stock position as of Q4 2018 after selling out during the quarter.
Kessler Investment Group sold 12,358 Endocyte, Inc. Common Stock shares in Q4 2018, an estimated $219K.
Kessler Investment Group first reported a position in Endocyte, Inc. Common Stock in Q2 2013 and held it in 5 quarters.
Kessler Investment Group's Endocyte, Inc. Common Stock position peaked at $219K in Q3 2018.
2 funds tracked by Wall St. Rank held Endocyte, Inc. Common Stock as of Q4 2018.

Based on Kessler Investment Group's 13F filing for Q4 2018, filed 11 Jan 2019.